Free Trial
NASDAQ:IONM

Assure 8/14/2023 Earnings Report

Assure logo
$0.03 0.00 (0.00%)
As of 07/11/2025

Assure EPS Results

Actual EPS
-$29.34
Consensus EPS
-$57.42
Beat/Miss
Beat by +$28.08
One Year Ago EPS
N/A

Assure Revenue Results

Actual Revenue
$1.54 million
Expected Revenue
$6.51 million
Beat/Miss
Missed by -$4.97 million
YoY Revenue Growth
N/A

Assure Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Assure Earnings Headlines

Assure Holdings Corp Ordinary Shares (IONM)
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
KDA GROUP INC, (KDAGF)
See More Assure Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Assure? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Assure and other key companies, straight to your email.

About Assure

Assure (NASDAQ:IONM) (NASDAQ:IONM) is a leading provider of remote intraoperative neuromonitoring (IONM) services in North America. The company offers real-time neurophysiological monitoring solutions designed to reduce the risk of nerve injury during complex surgical procedures. Utilizing a proprietary, cloud-based platform, Assure connects surgical teams with board-certified neurophysiologists who continuously track neural signals and deliver immediate feedback to surgeons across multiple operating rooms.

Through its digital infrastructure, Assure supports a comprehensive suite of monitoring modalities, including somatosensory evoked potentials (SSEP), motor evoked potentials (MEP), electromyography (EMG) and electroencephalography (EEG). The platform captures high-fidelity electrophysiological data, applies advanced analytics and generates customized reports to inform intraoperative decision-making. In addition to core monitoring services, the company provides training, technical support and structured quality assurance programs to maintain consistent clinical standards.

Founded in 2015 and headquartered in Salt Lake City, Utah, Assure has expanded rapidly to serve more than 500 hospitals and ambulatory surgical centers across 40 states. Its services span orthopedic, cardiovascular, spinal, neurosurgical and otolaryngology procedures, with strategic partnerships extending its reach into both major metropolitan medical centers and regional healthcare facilities. The company continues to invest in R&D to enhance telemedicine capabilities and develop new monitoring applications.

Assure’s leadership team combines deep expertise in healthcare technology and clinical practice. Co-founder and Chief Executive Officer Andrew S. Rich previously held senior executive roles at global medical device firms, while Chief Medical Officer Dr. Michael E. Stevens brings over two decades of neuromonitoring experience. Chief Financial Officer Karen T. Liu oversees financial strategy and operations. Together with a clinical advisory board of leading neurosurgeons, they guide Assure’s mission to improve surgical safety through innovative monitoring solutions.

View Assure Profile

More Earnings Resources from MarketBeat